Eva Wex

1.7k total citations · 1 hit paper
10 papers, 904 citations indexed

About

Eva Wex is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Eva Wex has authored 10 papers receiving a total of 904 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 6 papers in Pulmonary and Respiratory Medicine and 2 papers in Genetics. Recurrent topics in Eva Wex's work include Asthma and respiratory diseases (8 papers), Mast cells and histamine (2 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). Eva Wex is often cited by papers focused on Asthma and respiratory diseases (8 papers), Mast cells and histamine (2 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers). Eva Wex collaborates with scholars based in Germany, Switzerland and Austria. Eva Wex's co-authors include Lutz Wollin, Gisela Schnapp, Alexander Pautsch, Susanne Stowasser, Katrin Hostettler, Martin Kolb, Florian Gantner, Michael P. Sanderson, Andreas Schnapp and Michael Pieper and has published in prestigious journals such as PLoS ONE, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

Eva Wex

10 papers receiving 891 citations

Hit Papers

Mode of action of nintedanib in the treatment of idiopath... 2015 2026 2018 2022 2015 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eva Wex Germany 9 635 233 186 112 94 10 904
Fabienne Prost France 8 241 0.4× 85 0.4× 183 1.0× 259 2.3× 63 0.7× 10 765
Toyoshi Yanagihara Japan 17 423 0.7× 107 0.5× 235 1.3× 160 1.4× 48 0.5× 79 833
Yidong Fan China 19 269 0.4× 146 0.6× 559 3.0× 42 0.4× 27 0.3× 50 942
Donald K. Wood United States 12 252 0.4× 314 1.3× 249 1.3× 170 1.5× 90 1.0× 16 850
Toshiyuki Sumi Japan 16 257 0.4× 75 0.3× 297 1.6× 47 0.4× 26 0.3× 138 803
B.J. Moss United States 11 767 1.2× 45 0.2× 691 3.7× 56 0.5× 39 0.4× 16 1.3k
Edgar F. Smeets Netherlands 11 124 0.2× 201 0.9× 412 2.2× 328 2.9× 44 0.5× 11 1.1k
Michael Gormley United States 17 302 0.5× 60 0.3× 541 2.9× 84 0.8× 15 0.2× 47 919
Yasmina Bauer Switzerland 10 260 0.4× 57 0.2× 252 1.4× 44 0.4× 17 0.2× 12 589

Countries citing papers authored by Eva Wex

Since Specialization
Citations

This map shows the geographic impact of Eva Wex's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Wex with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Wex more than expected).

Fields of papers citing papers by Eva Wex

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Wex. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Wex. The network helps show where Eva Wex may publish in the future.

Co-authorship network of co-authors of Eva Wex

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Wex. A scholar is included among the top collaborators of Eva Wex based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Wex. Eva Wex is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Herrmann, Franziska, et al.. (2017). Olodaterol shows anti‐fibrotic efficacy in in vitro and in vivo models of pulmonary fibrosis. British Journal of Pharmacology. 174(21). 3848–3864. 17 indexed citations
3.
Wollin, Lutz, Eva Wex, Alexander Pautsch, et al.. (2015). Mode of action of nintedanib in the treatment of idiopathic pulmonary fibrosis. European Respiratory Journal. 45(5). 1434–1445. 698 indexed citations breakdown →
4.
Wex, Eva & Thierry Bouyssou. (2015). Olodaterol Attenuates Citric Acid-Induced Cough in Naïve and Ovalbumin-Sensitized and Challenged Guinea Pigs. PLoS ONE. 10(3). e0119953–e0119953. 10 indexed citations
5.
Wex, Eva, et al.. (2015). The long‐acting β2‐adrenoceptor agonist olodaterol attenuates pulmonary inflammation. British Journal of Pharmacology. 172(14). 3537–3547. 15 indexed citations
7.
Wex, Eva, et al.. (2014). A Novel Model of IgE-Mediated Passive Pulmonary Anaphylaxis in Rats. PLoS ONE. 9(12). e116166–e116166. 13 indexed citations
8.
Tautermann, Christofer S., Tobias Kiechle, Daniel Seeliger, et al.. (2013). Molecular Basis for the Long Duration of Action and Kinetic Selectivity of Tiotropium for the Muscarinic M3 Receptor. Journal of Medicinal Chemistry. 56(21). 8746–8756. 75 indexed citations
9.
Wex, Eva, Thierry Bouyssou, Klaus J. Erb, et al.. (2011). Induced Syk deletion leads to suppressed allergic responses but has no effect on neutrophil or monocyte migration in vivo. European Journal of Immunology. 41(11). 3208–3218. 24 indexed citations
10.
Sanderson, Michael P., Eva Wex, Takeshi Kono, Katsuhiro Uto, & Andreas Schnapp. (2010). Syk and Lyn mediate distinct Syk phosphorylation events in FcɛRI-signal transduction: Implications for regulation of IgE-mediated degranulation. Molecular Immunology. 48(1-3). 171–178. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026